News24 | Nestlé plans new products to manage ‘Ozempic face’ and other weight loss side effects 

​Nestlé is looking to turn the rise of GLP-1 weight loss drugs from a threat into a business opportunity, using AI and nutritional science to develop products for millions of consumers taking medicines such as Ozempic and Wegovy.   

Leave a Reply

Your email address will not be published. Required fields are marked *